One study investigating the genetics of secondary GBM found 39% of secondary GBM contained BRAF V600E mutations, while none contained BRAF fusions or IDH1 mutations, suggesting BRAF V600E either permits or promotes malignant transformation [92]. This evidence concerns the gene IDH1 and glioblastoma.